(DHR)

Role: SVP - Corporate Development
Signature: /s/ James F. O'Reilly, attorney-in-fact for Daniel A. Raskas
Stock symbol: DHR
Transactions as of: Nov 25, 2024
Transactions value $: -$6,676,585
Form type: 4
Date filed: 11/27/2024, 05:01 PM
Previous filing: Jul 26, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DHR	Common Stock	Sale	-$1.99M	-8.37K	-35.47%	$238.00	15.2K	Nov 25, 2024	Direct
transaction	DHR	Common Stock	Options Exercise	$1.54M	+26.3K	+172.86%	$58.59	41.5K	Nov 26, 2024	Direct
transaction	DHR	Common Stock	Sale	-$6.23M	-26.3K	-63.35%	$236.59	15.2K	Nov 26, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DHR	Employee stock option (right to buy)	Options Exercise	$0	-26.3K	-100%	$0.00	0	Nov 26, 2024	Common Stock	26.3K	$58.59	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.515 to $236.700, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
F2	One third of the options granted became exercisable on each of the third, fourth and fifth anniversaries of the grant date, which was February 24, 2016.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.515 to $236.700, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.

One third of the options granted became exercisable on each of the third, fourth and fifth anniversaries of the grant date, which was February 24, 2016.